UDIV-B:CA:TSX-Manulife Smart U.S. Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 14.54

Change

0.00 (0.00)%

Market Cap

CAD 0.10B

Volume

200.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

+0.22 (+0.67%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

+0.03 (+0.14%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.42 (+1.17%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+0.37 (+0.82%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.12 (+0.47%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.04 (+0.36%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

CAD 2.68B

ETFs Containing UDIV-B:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.23% 69% C- 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.23% 69% C- 64% D
Trailing 12 Months  
Capital Gain 22.70% 63% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.70% 63% D 62% D
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.62% 60% D- 49% F
Dividend Return 3.70% 59% D- 44% F
Total Return 0.08% 46% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 6.77% 64% D 83% B
Risk Adjusted Return 54.72% 75% C 70% C-
Market Capitalization 0.10B 63% D 34% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.